Yüksel Ürün/X
Aug 26, 2025, 08:07
Yüksel Ürün Highlighted a Study on GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X:
“In a cohort of 86,632 adults with obesity, GLP-1 receptor agonists were linked to lower overall cancer risk.
- Notably decreased risk: endometrial, ovarian, meningioma.
- But signal for increased kidney cancer risk.
Balance of benefit and caution.”
Title: GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity
Authors: Hao Dai, Yongqiu Li, Yao An Lee, Ying Lu, Thomas J. George, William T. Donahoo, Kelvin P. Lee, Harikrishna Nakshatri, John Allen, Yi Guo, Ramon C. Sun, Jingchuan Guo, Jiang Bian
Read the Full Article.
More posts featuring Yüksel Ürün.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 26, 2025, 07:26
Aug 26, 2025, 07:13
Aug 26, 2025, 06:51
Aug 26, 2025, 06:14
Aug 26, 2025, 05:57
Aug 26, 2025, 00:03